MX2016012553A - Pharmaceutical compositions of mazindol with metformin for weight loss. - Google Patents
Pharmaceutical compositions of mazindol with metformin for weight loss.Info
- Publication number
- MX2016012553A MX2016012553A MX2016012553A MX2016012553A MX2016012553A MX 2016012553 A MX2016012553 A MX 2016012553A MX 2016012553 A MX2016012553 A MX 2016012553A MX 2016012553 A MX2016012553 A MX 2016012553A MX 2016012553 A MX2016012553 A MX 2016012553A
- Authority
- MX
- Mexico
- Prior art keywords
- mazindol
- metformin
- pharmaceutical compositions
- weight loss
- actives
- Prior art date
Links
- ZPXSCAKFGYXMGA-UHFFFAOYSA-N Mazindol Chemical group N12CCN=C2C2=CC=CC=C2C1(O)C1=CC=C(Cl)C=C1 ZPXSCAKFGYXMGA-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000299 mazindol Drugs 0.000 title abstract 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003105 metformin Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000004580 weight loss Effects 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010033307 Overweight Diseases 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to pharmaceutical compositions comprising therapeutically effective amounts of the combination with additive effect of mazindol and metformin actives, and their use in medicine elaboration for the treatment of overweight and obesity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2016012553A MX2016012553A (en) | 2016-09-26 | 2016-09-26 | Pharmaceutical compositions of mazindol with metformin for weight loss. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2016012553A MX2016012553A (en) | 2016-09-26 | 2016-09-26 | Pharmaceutical compositions of mazindol with metformin for weight loss. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016012553A true MX2016012553A (en) | 2017-06-14 |
Family
ID=59684212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016012553A MX2016012553A (en) | 2016-09-26 | 2016-09-26 | Pharmaceutical compositions of mazindol with metformin for weight loss. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX2016012553A (en) |
-
2016
- 2016-09-26 MX MX2016012553A patent/MX2016012553A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025009223A (en) | Clec9a binding agents and use thereof | |
| PH12019501970A1 (en) | Pharmaceutical compositions for combination therapy | |
| PH12016501139A1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| MX2020009780A (en) | Autotaxin inhibitor compounds. | |
| PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| MY187540A (en) | Compounds active towards bromodomains | |
| PH12019501301A1 (en) | Pharmaceutical compositions for combination therapy | |
| MX2017002816A (en) | Pyrazolopyridine derivatives and their use in therapy. | |
| PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
| MX2014008705A (en) | Tricyclic sulfone compounds and methods of making and using same. | |
| EA201491532A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR USE IN COMPLEX THERAPY | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MX2015005732A (en) | Tricyclic compounds and methods of making and using same. | |
| MX2015005733A (en) | Tricyclic compounds for use in the treatment and/or control of obesity. | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| MX370436B (en) | Pharmaceutical composition for use in the treatment or prevention of vitamin and mineral deficiencies in patients which have been subjected to gastric bypass-surgery. | |
| ZA201906153B (en) | Pharmaceutical compositions for combination therapy | |
| MX2016012553A (en) | Pharmaceutical compositions of mazindol with metformin for weight loss. | |
| MA39009A (en) | Compositions pharmaceutiques comprenant un agent actif | |
| MX2018015240A (en) | Compositions comprising timolol and their use in the treatment of rosacea by topical administration. | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| EA201991733A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY | |
| EA201992151A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY | |
| MX2016011140A (en) | Presente en:. | |
| MX2016010022A (en) | Pharmaceutical composition of amfepramone and topiramate useful in the overweight and obesity treatment. |